Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Medbil Oy
OY
In liquidation
Y-tunnus 3178486-4
Sähköttäjänkatu 2-C29
General medical practice activities · NACE 8621
Est. 2020
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
EUR 0
EBITDA margin
—
+99% vs 2023
Equity ratio
-855.2%
Financial strength
Net profit 2024
EUR -1K
+99% vs 2023
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
EUR 0
—
EBITDA
EUR -1K
+99%
Net profit
EUR -1K
+99%
Total assets
EUR 116
-89%
Equity
EUR -992
-601%
Employees
1
—
Company information
Legal name
Medbil Oy
Y-tunnus number
3178486-4
Legal form
Osakeyhtiö
NACE code
8621 · General medical practice activities
Founded
18. joulukuuta 2020
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Terveydenhuolto
Contact
Address
Sähköttäjänkatu 2-C29
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
EUR thousands
Item
2021
2022
2023
2024
Revenue
171
0
0
0
Staff expenses
−36
−0
−72
−0
EBITDA
131
−9
−80
−1
Depreciation & amort.
—
—
−0
−0
EBIT
131
−9
−80
−1
Net financials
−0
−1
0
0
Profit before tax
131
−9
−80
−1
Tax
26
−0
−0
−0
Net profit
105
−9
−80
−1
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
Total assets
116
88
1
0
Equity
105
87
0
−1
Long-term debt
—
—
0
0
Short-term debt
12
1
1
1
Total debt
12
1
1
1
Financial ratios
5-year trend
EBITDA margin
-119100.0%
This company
15.8%
Market median
-753897% vs market
2021
2024
Equity ratio
-855.2%
This company
38.2%
Market median
-2339% vs market
2021
2024
Return on equity
-119100.0%
This company
18.4%
Market median
-647383% vs market
2021
2024
Net profit margin
-119100.0%
This company
8.1%
Market median
-1470470% vs market
2021
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2024
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-12-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MM
Marjo Melina Lund-Penttilä
Liquidator
Liquidator
2024
Former (2)
AM
Abdillahi Mohamed Dinbil
Chief Executive Officer
Chief Executive Officer
2021 – 2024
FM
Faisa Mahad Abdirisaag
Deputy Member
Deputy Member
2021 – 2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Medbil Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Abdillahi Mohamed Dinbil
Chief Executive Officer
0 companies
Marjo Melina Lund-Penttilä
Liquidator
0 companies
Faisa Mahad Abdirisaag
Deputy Member
0 companies